在RANKL抑制降低心脏缩
Laetitia Marcadet1, Emma Sara Juracic2, Nasrin Khan3
1Centre Hospitalier Universitaire de Québec, Centre de Recherche du Centre Hospitalier de l'Université Laval (CHUQ-CHUL), Axe Neurosciences, Université Laval, Quebec City, QC G1V 4G2, Canada.
Cells
|June 10, 2023
概括
抗RANKL疗法在杜氏肌力发育不良 (DMD) 鼠标模型中预防心脏缩和功能障碍. 这种方法可以在患有DMD的人类患者中保持心脏功能.
科学领域:
- 生物医学研究生物医学研究
- 心血管科学 心血管科学
- 肌肉骨系统疾病 肌肉骨系统疾病
背景情况:
- 心肌病是杜氏肌力发育不良症 (DMD) 的首要死亡原因.
- 核因子KB连接体 (RANKL) 的受体激活剂及其受体 (RANK) 途径与肌肉和骨健康有关.
- 在心脏组织中存在RANKL和RANK,这表明它在心脏功能中起作用.
研究的目的:
- 为了研究抗RANKL治疗在预防心脏缩和功能障碍的有效性,在缺素 (mdx) 的小鼠.
- 探索抗RANKL疗法的心脏保护作用背后的分子机制.
主要方法:
- 用一种抗RANKL药物治疗mdx小鼠.
- 评估心脏结构和功能,包括左心室 (LV) 缩和心脏质量.
- 对关键信号通路 (NFκB,PI3K) 和处理蛋白 (SERCA,RyR,FKBP12) 的分析.
主要成果:
- 在mdx小鼠中,抗RANKL治疗显著降低了LV缩和心脏质量.
- 在接受抗RANKL治疗的mdx小鼠中,心脏功能被保留了.
- 治疗抑制了NFκB和PI3K通路,并改善了处理标记物 (SERCA活性,RyR,FKBP12,SERCA2a表达).
结论:
- 抗RANKL疗法在预防DMD中心脏缩进展方面显示出潜在的潜力.
- 这种治疗策略可能有助于在患有DMD的个体中维持心脏功能.
- 初步的人类数据表明,登索马布可能会降低DMD患者的左心室缩.
更多相关视频
08:34Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
Published on: September 25, 2017
24.5K
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
6.2K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
470
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
470
01:22Heart Failure Drugs: Diuretics
428
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
428
01:20Mitral Regurgitation I: Introduction
19
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
19
01:29Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
01:22Mitral Stenosis I: Introduction
19
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
19